| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/1993 | US5211945 Compositions and methods for modulating the effect of tnf and il-1 |
| 05/18/1993 | US5211944 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 05/18/1993 | US5211943 Pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture |
| 05/18/1993 | US5211941 Shampoo surfactants, alcohol, water, oil |
| 05/18/1993 | US5211940 Transparent liquid oral composition |
| 05/18/1993 | US5211938 Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors |
| 05/18/1993 | US5211937 Method of determining a site of inflammation utilizing elam-1 ligands |
| 05/18/1993 | US5211936 Endothelial leukocyte adhesion molecule |
| 05/18/1993 | CA1318078C Ion exchange resins loaded with quinolonecarboxylic acid derivatives, their preparation and use |
| 05/18/1993 | CA1317973C Tetralin derivatives, their preparation and their use |
| 05/18/1993 | CA1317964C N-phenyl butenamides with pharmaceutical properties |
| 05/18/1993 | CA1317962C Cell proliferation inhibitors |
| 05/18/1993 | CA1317960C Derivatives of bicyclic aminocarboxylic acids, a process and intermediates for their preparation, and their use |
| 05/18/1993 | CA1317959C 5-(_-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes |
| 05/18/1993 | CA1317958C Substituted benzimidazoles and benzothidiazoles |
| 05/18/1993 | CA1317956C Basic-substituted 5-halo-thienoisothiazol-3(2h)-one 1, 1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds |
| 05/18/1993 | CA1317955C 3-¬4(1-substituted-4-piperazinyl)butyl|-4- thiazolidinones a process for their preparation and their use as medicaments |
| 05/18/1993 | CA1317953C Antiulcer (alkyldithio) quinoline derivatives |
| 05/18/1993 | CA1317951C Substituted n-(3-hydroxy-4-piperidinyl)-benzamides |
| 05/18/1993 | CA1317948C Omega-¬(hetero)alkyl|benz¬cd|-indol-2-amines |
| 05/18/1993 | CA1317946C Antiulcer pyrimidine derivatives |
| 05/18/1993 | CA1317945C Tricyclic pyridazopyridone derivatives |
| 05/18/1993 | CA1317944C 2-amino-4-morpholino-6-propyl-1,3,5-triazines |
| 05/18/1993 | CA1317942C 5-hetero-or aryl-substituted-imidazol¬2,1-a| isoquinolines |
| 05/18/1993 | CA1317941C Piperidine derivative and pharmaceutical composition containing the same |
| 05/18/1993 | CA1317940C Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
| 05/18/1993 | CA1317939C ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines |
| 05/18/1993 | CA1317938C Benzazapin derivatives |
| 05/18/1993 | CA1317936C Mono and diacyl derivatives of ll-f28249 compounds |
| 05/18/1993 | CA1317935C Macrolide compounds, their preparation and their use |
| 05/18/1993 | CA1317884C Treatment of skin diseases and tumors |
| 05/18/1993 | CA1317881C Aerosol compositions for nasal delivery of vitamin b__ |
| 05/16/1993 | WO1993009783A1 Anti-inflammatory and analgesic plaster |
| 05/16/1993 | CA2121603A1 Antiphlogistic-analgesic plaster |
| 05/16/1993 | CA2082774A1 Saccharin derivative proteolytic enzyme inhibitors |
| 05/16/1993 | CA2082693A1 Use of cosmetic compositon |
| 05/16/1993 | CA2079822A1 2-substituted saccharin derivative proteolytic enzyme inhibitors |
| 05/16/1993 | CA2066983A1 Method for treatment for neuro-muscular incontinence |
| 05/15/1993 | WO1993009791A2 Use of amphotericin b derivatives as protease inhibitors |
| 05/15/1993 | CA2099490A1 Use of amphotericin b derivatives as protease inhibitors |
| 05/15/1993 | CA2082856A1 3-sulfonylamino-2-(1h)-quinoleinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/15/1993 | CA2082562A1 The use of preparations of curcuma plants |
| 05/15/1993 | CA2082489A1 Parasiticides |
| 05/14/1993 | CA2082787A1 Substituted n-biphenylyl lactams |
| 05/14/1993 | CA2055378A1 Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
| 05/13/1993 | WO1993009236A1 Myogenic vector systems |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009133A1 C8-cyclic peptidomimetics as fibrinogen antagonists |
| 05/13/1993 | WO1993009132A1 Hiv protease inhibitors containing guanidine |
| 05/13/1993 | WO1993009126A1 New a83543 compounds and process for production thereof |
| 05/13/1993 | WO1993009124A1 Photosensitizers |
| 05/13/1993 | WO1993009122A1 Cns active tetrahydrobenzothienopyridines |
| 05/13/1993 | WO1993009119A1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines |
| 05/13/1993 | WO1993009118A1 1,3-dihydro-2h-imidazo(4,5-b)quinolin-2-one derivatives as phosphodiesterase inhibitors |
| 05/13/1993 | WO1993009117A1 Immunostimulating swainsonine analogs |
| 05/13/1993 | WO1993009115A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors |
| 05/13/1993 | WO1993009114A1 Tri-substituted tetrahydrofuran antifungals |
| 05/13/1993 | WO1993009110A1 Compound dc8118 |
| 05/13/1993 | WO1993009107A1 Novel process for the preparation of 4-methyl-5-(2-chloroethyl)-thiazole and analogues thereof |
| 05/13/1993 | WO1993009105A1 Substituted dibenzoxazepine compounds as analgesic agents |
| 05/13/1993 | WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 05/13/1993 | WO1993009103A1 Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| 05/13/1993 | WO1993009102A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 05/13/1993 | WO1993009101A1 Mercapto-amide derivatives as inhibitors of the neutral endopeptidase |
| 05/13/1993 | WO1993009098A1 Novel 4-cinnolinone derivatives, their preparation and application in therapy |
| 05/13/1993 | WO1993009097A1 Collagenase inhibitor |
| 05/13/1993 | WO1993009096A1 Hiv protease inhibitors useful for the treatment of aids |
| 05/13/1993 | WO1993009095A1 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 05/13/1993 | WO1993009093A1 Vitamin d amide derivatives |
| 05/13/1993 | WO1993009090A1 Hydroxamic acid derivative |
| 05/13/1993 | WO1993009089A1 Bistriazenes as chemotherapeutic agents |
| 05/13/1993 | WO1993009085A1 Nitroxyalkylamide derivative |
| 05/13/1993 | WO1993009075A1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 05/13/1993 | WO1993008813A1 Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis |
| 05/13/1993 | WO1993008810A1 Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 05/13/1993 | WO1993008809A1 Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| 05/13/1993 | WO1993008808A2 Use of gangliosides in the preparation of pharmaceuticals which can improve the progonosis of disorders due to psychotropics and drugs abuse |
| 05/13/1993 | WO1993008807A1 Phospholipid antimicrobial compositions |
| 05/13/1993 | WO1993008806A1 Reducing tetracycline resistance in living cells |
| 05/13/1993 | WO1993008805A1 Drugs for treating aids |
| 05/13/1993 | WO1993008804A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 05/13/1993 | WO1993008802A1 Liposome preparation containing tricyclic compound |
| 05/13/1993 | WO1993008801A1 Prevention of drug-induced agranulocytosis with free radical scavengers |
| 05/13/1993 | WO1993008800A1 Potassium channel activating compounds and methods of use thereof |
| 05/13/1993 | WO1993008799A1 Endothelin receptor antagonists |
| 05/13/1993 | WO1993008798A1 Pentadimine transdermal composition and patch |
| 05/13/1993 | WO1993008797A1 Hypericin compositions for treating t-cell mediated diseases |
| 05/13/1993 | WO1993008795A1 Transdermal therapeutic systems containing crystallization inhibitors |
| 05/13/1993 | WO1993008790A1 Treatment of acne or of pseudofolliculitis barbae |
| 05/13/1993 | WO1993008688A1 Method and composition for treating tumors having high tyrosinase activity |
| 05/13/1993 | WO1993008687A1 Alteration of rate and character of hair growth |
| 05/13/1993 | DE4137548A1 Antimicrobial compsn. for antiseptic and disinfectant - contg. acridine dye, chlorhexidine, octenidine, quat. ammonium cpd., iodophor or lactic acid, for skin, mucous membranes and wounds |
| 05/13/1993 | DE4137544A1 Antimicrobial compsn. for antiseptic and disinfectant for skin - comprises cpds. yielding oxygen@ and chlorine@ quat. ammonium cpd., surfactant, aluminium chloride carbamide, urea, allantoin, panthenol and lactic acid |
| 05/13/1993 | DE4137009A1 New inhibitors of cellular transport systems for organic cations - useful in improving effectiveness of hormones and neuro-transmitters |
| 05/13/1993 | CA2124856A1 Potassium channel activating compounds and methods of use thereof |
| 05/13/1993 | CA2123104A1 Collagenase inhibitor |
| 05/13/1993 | CA2123098A1 Immunostimulating swainsonine analogs |
| 05/13/1993 | CA2123096A1 Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| 05/13/1993 | CA2123007A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |